慢性呼吸系统疾病患者肺康复利用：2014-2019

IF 3.5 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Respiratory medicine Pub Date : 2025-04-22 DOI:10.1016/j.rmed.2025.108110

A. Matta , E. Polychronopoulou , Y.-F. Kuo , G. Sharma , A.G. Duarte

{"title":"慢性呼吸系统疾病患者肺康复利用：2014-2019","authors":"A. Matta , E. Polychronopoulou , Y.-F. Kuo , G. Sharma , A.G. Duarte","doi":"10.1016/j.rmed.2025.108110","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Chronic respiratory diseases are associated with significant disability and death. Pulmonary rehabilitation (PR) is recommended in the management of chronic respiratory diseases. There is limited population level data comparing PR utilization and completion among patients with chronic respiratory diseases.</div></div><div><h3>Methods</h3><div>A retrospective, cross sectional analysis concerning PR use in adults residing in the U.S. with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), idiopathic pulmonary fibrosis (IPF), pulmonary hypertension, and bronchiectasis was conducted using the Merative™ MarketScan® Research Databases. PR use was identified using current procedural terminology (CPT) and healthcare common procedure coding system (HCPCS) codes. Demographics, comorbidities, oxygen use, medications, initiation and participation of PR by disease state were collected. Analysis involved chi-square tests and generalized estimating equations.</div></div><div><h3>Results</h3><div>From 2014 to 2019, we identified 892,741 adults with chronic respiratory diseases and COPD was the most prevalent. PR initiation occurred in 2.3 % and annual participation ranged from 1.5 % to 1.7 %. The IPF group had the largest proportion of patients that initiated PR compared to other groups. Completion of ≥8 sessions was greatest for the group with IPF (60.8 %), followed by non IPF ILD (56.2 %), bronchiectasis (55.3 %), pulmonary hypertension (55.1 %) and COPD (53.9 %). Completion of ≥8 sessions was significantly greater for the IPF group compared to the COPD group, (p < 0.0001).</div></div><div><h3>Conclusion</h3><div>PR was underutilized among individuals with chronic respiratory disease, however the group with IPF demonstrated the greatest proportion of PR initiation and completion compared with other groups.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"242 ","pages":"Article 108110"},"PeriodicalIF":3.5000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pulmonary rehabilitation utilization in patients with chronic respiratory diseases: 2014–2019\",\"authors\":\"A. Matta , E. Polychronopoulou , Y.-F. Kuo , G. Sharma , A.G. Duarte\",\"doi\":\"10.1016/j.rmed.2025.108110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Chronic respiratory diseases are associated with significant disability and death. Pulmonary rehabilitation (PR) is recommended in the management of chronic respiratory diseases. There is limited population level data comparing PR utilization and completion among patients with chronic respiratory diseases.</div></div><div><h3>Methods</h3><div>A retrospective, cross sectional analysis concerning PR use in adults residing in the U.S. with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), idiopathic pulmonary fibrosis (IPF), pulmonary hypertension, and bronchiectasis was conducted using the Merative™ MarketScan® Research Databases. PR use was identified using current procedural terminology (CPT) and healthcare common procedure coding system (HCPCS) codes. Demographics, comorbidities, oxygen use, medications, initiation and participation of PR by disease state were collected. Analysis involved chi-square tests and generalized estimating equations.</div></div><div><h3>Results</h3><div>From 2014 to 2019, we identified 892,741 adults with chronic respiratory diseases and COPD was the most prevalent. PR initiation occurred in 2.3 % and annual participation ranged from 1.5 % to 1.7 %. The IPF group had the largest proportion of patients that initiated PR compared to other groups. Completion of ≥8 sessions was greatest for the group with IPF (60.8 %), followed by non IPF ILD (56.2 %), bronchiectasis (55.3 %), pulmonary hypertension (55.1 %) and COPD (53.9 %). Completion of ≥8 sessions was significantly greater for the IPF group compared to the COPD group, (p < 0.0001).</div></div><div><h3>Conclusion</h3><div>PR was underutilized among individuals with chronic respiratory disease, however the group with IPF demonstrated the greatest proportion of PR initiation and completion compared with other groups.</div></div>\",\"PeriodicalId\":21057,\"journal\":{\"name\":\"Respiratory medicine\",\"volume\":\"242 \",\"pages\":\"Article 108110\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0954611125001726\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611125001726","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

慢性呼吸系统疾病与严重的残疾和死亡相关。肺康复（PR）被推荐用于慢性呼吸系统疾病的治疗。比较慢性呼吸系统疾病患者PR使用和完成情况的人口水平数据有限。方法使用Merative™MarketScan®研究数据库，对美国慢性阻塞性肺疾病（COPD）、间质性肺疾病（ILD）、特发性肺纤维化（IPF）、肺动脉高压和支气管扩张的成人PR使用情况进行回顾性、横断面分析。使用现行程序术语（CPT）和医疗保健通用程序编码系统（HCPCS）代码确定PR的使用。统计数据、合并症、氧气使用、药物、PR的开始和参与情况。分析涉及卡方检验和广义估计方程。结果2014 - 2019年，共发现892,741例成人慢性呼吸系统疾病，其中COPD最为常见。PR起始率为2.3%，年参与率为1.5%至1.7%。与其他组相比，IPF组启动PR的患者比例最大。IPF组完成≥8次治疗的比例最高（60.8%），其次是非IPF组（56.2%）、支气管扩张（55.3%）、肺动脉高压（55.1%）和COPD（53.9%）。与COPD组相比，IPF组完成≥8个疗程的患者显著增加(p <；0.0001)。结论慢性呼吸系统疾病患者PR利用不足，但IPF组PR启动和完成比例高于其他组。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Pulmonary rehabilitation utilization in patients with chronic respiratory diseases: 2014–2019

Background

Chronic respiratory diseases are associated with significant disability and death. Pulmonary rehabilitation (PR) is recommended in the management of chronic respiratory diseases. There is limited population level data comparing PR utilization and completion among patients with chronic respiratory diseases.

Methods

A retrospective, cross sectional analysis concerning PR use in adults residing in the U.S. with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), idiopathic pulmonary fibrosis (IPF), pulmonary hypertension, and bronchiectasis was conducted using the Merative™ MarketScan® Research Databases. PR use was identified using current procedural terminology (CPT) and healthcare common procedure coding system (HCPCS) codes. Demographics, comorbidities, oxygen use, medications, initiation and participation of PR by disease state were collected. Analysis involved chi-square tests and generalized estimating equations.

Results

From 2014 to 2019, we identified 892,741 adults with chronic respiratory diseases and COPD was the most prevalent. PR initiation occurred in 2.3 % and annual participation ranged from 1.5 % to 1.7 %. The IPF group had the largest proportion of patients that initiated PR compared to other groups. Completion of ≥8 sessions was greatest for the group with IPF (60.8 %), followed by non IPF ILD (56.2 %), bronchiectasis (55.3 %), pulmonary hypertension (55.1 %) and COPD (53.9 %). Completion of ≥8 sessions was significantly greater for the IPF group compared to the COPD group, (p < 0.0001).

Conclusion

PR was underutilized among individuals with chronic respiratory disease, however the group with IPF demonstrated the greatest proportion of PR initiation and completion compared with other groups.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Respiratory medicine 医学-呼吸系统

CiteScore

7.50

自引率

0.00%

发文量

199

审稿时长

38 days

期刊介绍： Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants. Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.